Thiabendazole
Anthelmintic — DERMATOLOGICALS
Also known as: bovizole, equizole, mintesol, mintezol, minzolum, omnizole, thiabendazol, thiabendole, thiabenzole, thibendole, thibenzol, thibenzole
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Thiabendazole is an ofm drug in the Anthelmintic class catalogued in DrugCentral. It was first approved by the FDA in 1967. DrugCentral lists 10 molecular targets, including HDAC6, map and CYP1A2. Recorded indications include Ancylostoma Duodenale Infection, Ascariasis, Cutaneous larva migrans and Enterobiasis.
- Approval status: ofm (first approved 1967 by the FDA).
- Drug class: Anthelmintic.
- Molecular targets: HDAC6, map, CYP1A2 and METAP1 (10 listed in DrugCentral).
- Indications: Ancylostoma Duodenale Infection, Ascariasis, Cutaneous larva migrans, Enterobiasis and Infection by larvae of Trichinella spiralis and others.
- ATC code: D01AC06 (Imidazole and triazole derivatives).
- Molecular formula: C10H7N3S; molecular weight 201.25 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (10)
- Ancylostoma Duodenale Infection
- Ascariasis
- Cutaneous larva migrans
- Enterobiasis
- Infection by larvae of Trichinella spiralis
- Infection by Strongyloides
- Infection by Uncinaria
- Infection due to Toxocara
- Necator Americanus Infection
- Trichuriasis
Off-label uses (4)
- Capillaria infection
- Infection by Baylisascaris
- Infection by Dracunculus medinensis
- Trichostrongyliasis
Contraindications (3)
- Hepatic failure
- Kidney disease
- Liver function tests abnormal
Mechanism & targets
| Established pharmacologic class | Anthelmintic |
|---|
Molecular targets (10)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histone deacetylase 6 | HDAC6 | unknown | IC50 6.44 |
| Methionine aminopeptidase | map | unknown | IC50 6.33 |
| Cytochrome P450 1A2 | CYP1A2 | unknown | IC50 6.10 |
| Methionine aminopeptidase 1 | METAP1 | unknown | EC50 5.47 |
| Reverse transcriptase/RNaseH | pol | unknown | IC50 4.84 |
| Methionine aminopeptidase 2 | METAP2 | unknown | IC50 4.35 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | FKBP1A | unknown | Kd 4.22 |
| Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | sdha-1 | unknown | — |
| Tubulin | — | inhibitor | — |
| Tubulin | — | inhibitor | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1967-04-07 | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
D01AC06 | DERMATOLOGICALS › ANTIFUNGALS FOR DERMATOLOGICAL USE › ANTIFUNGALS FOR TOPICAL USE › Imidazole and triazole derivatives |
P02CA02 | ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTHELMINTICS › ANTINEMATODAL AGENTS › Benzimidazole derivatives |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Thiabendazole is on its molecule page.
| Molecular formula | C10H7N3S |
|---|---|
| Molecular weight | 201.25 g/mol |
| CAS number | 148-79-8 |
| InChIKey | WJCNZQLZVWNLKY-UHFFFAOYSA-N |
| PubChem CID | 5430 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Thiabendazole used for?
DrugCentral lists the following indications for Thiabendazole: Ancylostoma Duodenale Infection, Ascariasis, Cutaneous larva migrans, Enterobiasis, Infection by larvae of Trichinella spiralis, Infection by Strongyloides, Infection by Uncinaria and Infection due to Toxocara and others.
How does Thiabendazole work?
Its molecular targets in DrugCentral include HDAC6, map, CYP1A2 and METAP1.
When was Thiabendazole first approved?
Thiabendazole was first approved by the FDA in 1967.
What drug class does Thiabendazole belong to?
Thiabendazole is in the Anthelmintic class.
What is the chemical formula of Thiabendazole?
Thiabendazole has the molecular formula C10H7N3S and a molecular weight of 201.25 g/mol.
Browse: all drugs starting with T · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 2621 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL625 — compound record and bioactivity
- PubChem CID 5430 — chemical identifiers
- DrugBank DB00730 — drug record
- FDA UNII N1Q45E87DT — substance identity
- DailyMed: FDA labels for Thiabendazole — current prescribing information (label search)
- UniProt Q9UBN7 (HDAC6) — target protein
- UniProt P05177 (CYP1A2) — target protein
- UniProt P53582 (METAP1) — target protein
- UniProt P50579 (METAP2) — target protein
- UniProt P62942 (FKBP1A) — target protein
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.